Effective treatments for people with serious depression who have not been helped by antidepressant medications have novel ...

People with treatment-resistant depression can now take Spravato's ketamine-derived nasal spray as a standalone treatment.

The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used ...

The Food and Drug Administration on Tuesday approved Johnson & Johnson's nasal spray to be used alone in adults with a major ...

Here's what MDs want you to know about Spravato, the latest FDA-approved standalone nasal spray for depression.

CHARLOTTESVILLE, Va. (WVIR) - According to one UVA health expert, antidepressants, and medication prescribed to help people ...

CIII allows people who have tried at least two oral antidepressants to use the spray on its own – without the need for more ...

The treatment has become increasingly popular, especially among older men. Here is what to keep in mind if you are ...

“Major depression is one of the greatest ... patients will start getting relief from the esketamine treatment, and that relief can last to the duration study through 28 days of treatment that ...

The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used as a standalone treatment for patients with severe depression ...

Harmony, a mental health service provider in Charleston, is offering a non-invasive treatment that looks to help those with ...